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Abstract
Background: Microarray transcript profiling has the potential to illuminate the molecular
processes that are involved in the responses of cattle to disease challenges. This knowledge may
allow the development of strategies that exploit these genes to enhance resistance to disease in an
individual or animal population.
Results: The Bovine Innate Immune Microarray developed in this study consists of 1480
characterised genes identified by literature searches, 31 positive and negative control elements and
5376 cDNAs derived from subtracted and normalised libraries. The cDNA libraries were produced
from 'challenged' bovine epithelial and leukocyte cells. The microarray was found to have a limit of
detection of 1 pg/µg of total RNA and a mean slide-to-slide correlation co-efficient of 0.88. The
profiles of differentially expressed genes from Concanavalin A (ConA) stimulated bovine peripheral
blood lymphocytes were determined. Three distinct profiles highlighted 19 genes that were rapidly
up-regulated within 30 minutes and returned to basal levels by 24 h; 76 genes that were up-
regulated between 2–8 hours and sustained high levels of expression until 24 h and 10 genes that
were down-regulated. Quantitative real-time RT-PCR on selected genes was used to confirm the
results from the microarray analysis. The results indicate that there is a dynamic process involving
gene activation and regulatory mechanisms re-establishing homeostasis in the ConA activated
lymphocytes. The Bovine Innate Immune Microarray was also used to determine the cross-species
hybridisation capabilities of an ovine PBL sample.
Conclusion: The Bovine Innate Immune Microarray has been developed which contains a set of
well-characterised genes and anonymous cDNAs from a number of different bovine cell types. The
microarray can be used to determine the gene expression profiles underlying innate immune
responses in cattle and sheep.
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Microarray technology is a transcript profiling strategy
that allows simultaneous measurement of expression of
large numbers of genes in a sample. The expression of
thousands of genes can be rapidly monitored in different
biological samples allowing the identification of differen-
tially expressed genes. These data, often in conjunction
with pre-existing knowledge of specific biochemical path-
ways and networks, enable a greater understanding of the
molecular differences that contribute to the functional
specialisation of specific biological samples. Microarrays
also have the capacity to identify novel gene networks.
Whilst there are many sources and types of comprehen-
sive microarrays useful for applications with mouse and
human samples, microarrays specifically designed for use
with samples from production animals, particularly rumi-
nants are not widely available. Some studies have used
human or murine microarrays for applications with tis-
sues from livestock production animals [1,2]. However,
there is only an average of 86% nucleotide sequence iden-
tity between transcripts from cattle and either human or
mouse transcripts suggesting that cross-species hybridisa-
tions may provide relatively restricted information [1].
Recently, specialised or focused bovine cDNA microarrays
have been reported, which are suitable for studies with
specific tissues or physiological states. These microarrays
provide an excellent tool for examination of gene expres-
sion in a specific tissue (eg. muscle) but their general
availability is limited [3-9]. There are reports of a relatively
small bovine immune-endocrine cDNA microarray repre-
senting 167 genes [4] and a third generation immune
gene cDNA microarray constructed from bovine leuko-
cytes which contains 1250 genes [10]. Both of these
microarrays contain only a limited representation of the
many immune related genes, based on surveys of the
murine and human scientific literature. Recently, a rela-
tively comprehensive bovine cDNA microarray contain-
ing over 18,000 unique transcripts was announced but its
general availability is unclear [11]. A bovine Affymetrix
microarray has been released although the corresponding
gene annotations are limited and the technology is still
relatively expensive [12].
There is considerable interest in the identification of
bovine and ovine genes that contribute to the relative
resistance or susceptibility to disease. This is emphasised
by the lack of effective therapeutic strategies for a number
of diseases, the costs associated with existing treatments
and the range of diseases that need to be considered. For
one livestock disease alone, mastitis in dairy cows, it is
estimated that economic losses amount to 1.8 billion dol-
lars per annum in the USA, despite considerable manage-
ment and therapeutic interventions [13]. Mastitis is
caused by a wide range of gram negative and gram positive
bacteria that in some instances have developed resistance
to antibiotic treatment [14-16]. Many other diseases of
cattle are also of considerable economic and medical
importance eg. Leptospirosis and Johne's disease [17].
One strategy to efficiently counter the variety of infective
agents in livestock is to enhance their broad spectrum
innate immune resistance, either by marker assisted selec-
tive breeding to enrich for advantageous alleles, or active
modulation of pivotal proteins that increase broad dis-
ease resistance mechanisms. The biological feasibility of
these approaches is highlighted by animal breeds that are
inherently more resistant to some forms of diseases or
parasites as well as specific physiological states that high-
light disease susceptibility [18,19]. In addition, mouse
models clearly indicate that different strains can show
highly variable responses to bacterial challenge [20]. The
success of this strategy requires the identification of genes
that contribute to resistance mechanisms and to the
pathology of disease.
A bovine innate immune cDNA microarray has been con-
structed to allow identification of genes involved in
responses of cattle and sheep to disease challenges. It con-
sists of 1480 defined innate immune related genes
selected on the basis of their function in mammals and
5376 anonymous clones selected from subtracted and
normalised cDNA libraries constructed from a range of
'challenged' bovine epithelial and leukocyte cells. The
former group of genes were identified from a variety of
sources, primarily the mammalian literature, reporting
genes involved in innate immunity. The latter group
included genes produced by immune cells and epithelial
cells, recognising the important role of both cell types in
innate immunity [21]. The microarray was validated for
technical reproducibility and sensitivity using Concanav-
alin A (ConA) activation of bovine peripheral blood lym-
phocytes. ConA is a T-cell mitogenic lectin that is often
used to model lymphocyte activation responses and has
been extensively used in human and mouse studies [22].
In addition, it is demonstrated that the microarray is use-
ful for applications with ovine samples, as a result of the
relatively high sequence identity between ovine and
bovine transcripts (96 ± 2.4%) [23].
The Bovine Innate Immune Microarray will be useful for
monitoring gene expression changes as a response to
infection in a wide range of bovine and ovine tissues. This
knowledge may allow the development of strategies that
exploit these genes and the proteins they encode, leading
to enhanced disease resistance in an individual or animal
population. There is also increasing evidence for the
involvement of some innate immune system components
in normal physiological regulatory processes and hence
the microarray will also contribute to an understanding of
these processes [24].Page 2 of 22
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In this study "signal" refers to the background subtracted
mean fluorescence intensity and "element" refers to the
DNA amplicon printed onto the microarray slide surface.
Preparation of microarray elements
The Bovine Innate Immune Microarray contains 16,128
individually printed spots. These were made up of 1480
characterised bovine and ovine candidate genes identified
by manual literature searches; clones generated from sub-
tracted and normalised cDNA libraries derived from 'chal-
lenged' bovine cells and cell lines; and a series of positive
and negative control elements (Table 1). The majority of
the elements were printed in duplicate adjacent to each
other, in a configuration of 48 sub-arrays set out in 4 col-
umns and 12 rows. One 384-well plate of control ele-
ments was printed in duplicate at both the top and
bottom of each sub-array.
Plasmid clones corresponding to the majority of the can-
didate genes were identified in available cDNA libraries
including; Meat Animal Research Center (MARC) 1–5
libraries [25,26]. and CSIRO Livestock Industries ovine
and bovine cDNA libraries [27,28] (see Additional file 1).
Candidate genes and controls not present in the cDNA
libraries were amplified using gene specific primers (see
Additional file 2).
Subtracted, normalised cDNA libraries were constructed
using stimulated and unstimulated populations of
immune and epithelial cell types, including: bovine
peripheral blood lymphocytes (PBL); primary bovine
mammary epithelial cells (bMEC); an immortalised
bovine macrophage cell line (BoMAC); and an immortal-
ised bovine mammary epithelial cell line (MAC-T).
Bovine PBLs were stimulated with Concanavalin A
(ConA), whilst the bMEC, BoMAC and MAC-T cell lines
were stimulated with lipopolysaccharide (LPS).
The cDNA libraries were made using the Clontech PCR-
Select cDNA subtraction protocol as described in the
Methods section. The average insert length across all
libraries constructed was 450 bp. The effectiveness of
library normalisation was initially evaluated by DNA
sequence analysis. Fifty clones from each library were
sequenced and annotated by BLASTN and BLASTX
searches of the Genbank Non-Redundant and Human
RefSeq databases. The level of redundancy was calculated
by comparing the number of unique gene sequences to
the total number of clones sequenced. The average level of
redundancy of the subtracted and normalised cDNA
libraries was 26.6% with an inter-library redundancy rate
of 27.4%. The redundancy primarily consisted of clone
duplicates rather than many clones representing a small
number of abundant transcripts. Therefore, the maximum
number of genes represented on the microarray is approx-
imately 5400.
Analysis of microarray printing
The printed microarray elements were visualised by
hybridisation with Panomer™ 9 random
oligodeoxynucleotide, Alexa Fluor® 532 conjugate (Molec-
ular Probes, Invitrogen). The slides were visually
inspected for irregular or missing spots. The depletion of
some spots due to vaporisation or inconsistent pin depo-
sition was noted and taken into account during hybridisa-
tion analysis.
Fragments, 500 bp in length, from bovine β-actin and
GAPDH were printed in a dynamic range of 25, 50, 100,
200 and 400 pg/spot, (assuming an average deposition of
1 nl printing solution per spot; Rob Moore, personal com-
munication). The signal reported from these elements was
averaged across spotted replicates and showed an increase
in fluorescence intensity in proportion to the amount of
DNA in each spot, up to 200 pg (Fig. 1). However, the sig-
nal intensity reached a plateau in the elements containing
200–400 pg per spot, a phenomenon that may be due to
stearic hindrance or fluorescence quenching [29]. Using
the signal data reported by the dynamic range of β-actin
and GAPDH elements as a standard curve, the average
quantity of DNA printed for each element was 297 ± 52
pg/spot.
Analyses of DNA element quantity, length and position 
within the target transcript
A minimum quantity of spotted DNA is required to
ensure that spot morphology and reproducibility are opti-
mal. In addition, the spotted DNA needs to be in excess
over the target DNA to ensure that the fluorescence signal
is not limiting and proportional to the hybridised target
Table 1: Source of elements contributing to the Bovine Innate 
Immune Microarray
Origin of Microarray Probe Number of Elements
Literature candidates – Bovine 1310
Literature candidates – Ovine 170
Vectors, primers and blanks 8
Lucidea controls set 23
PBL – ConA 576
PBL – Control 960
BoMac – Control 480
BoMac – LPS 480
MAC-T (collagen) – Control 480
MAC-T (collagen) – LPS 480
MAC-T – Control 480
MAC-T – LPS 480
bMEC – Control 480
bMEC – LPS 480
Total 6887Page 3 of 22
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not influence the reported signal. The β-actin and GAPDH
control elements, which were printed in a range from 25–
400 pg/spot, were used to measure the effect of spot DNA
quantity on signal intensity. Data were taken from micro-
array slides hybridised with labelled cDNA from bovine
PBLs stimulated with ConA. The signals from replicate
control elements were averaged. β-actin and GAPDH ele-
ments report stable and reproducible signal when printed
at a quantity of 50–200 pg/spot (Fig. 2(a)). Elements with
a DNA quantity of 25 pg/spot have reduced signal
strength, presumably because the DNA in the spot was
limiting. Elements with a DNA quantity of 400 pg/spot
also have reduced signal strength, which may be caused by
competitive self hybridisation of the element DNA or pos-
sibly stearic hindrance of the fluorescent dyes. Therefore,
elements containing between 50–200 pgDNA/spot
should report accurate and reproducible signal using
labelled cDNA from biological samples.
Figure 2(b) shows the effect of varying the length of the
spotted β-actin and GAPDH cDNAs. Bovine β-actin and
GAPDH elements ranging in length from 200 to 1500 bp
from a common 3'-end were generated as described in the
Methods section. These elements were spotted onto the
microarray at a concentration of 200 pg/spot. Signal data
were taken from slides hybridised with labelled cDNA
from ConA stimulated bovine PBLs. The GAPDH ele-
Effect of DNA element quantity on signal from fluorescently lab lled random oligonucleotidesFigure 1
Effect of DNA element quantity on signal from fluo-
rescently labelled random oligonucleotides. The fluo-
rescence intensities of Panomer™ 9 random 
oligodeoxynucleotides, Alexa Fluor® 532 conjugate (Molecu-
lar Probes, Invitrogen) were measured after hybridisation to 
β-actin(◆) and GAPDH (■) control elements. These ele-
ments were spotted in a gradient of 25, 50, 100, 200 or 400 
pg DNA per spot. Error bars represent one standard devia-
tion of the mean.
Effect on the signal reported from DNA elements of varying quan ity, length and position within the target transcriptFigure 2
Effect on the signal reported from DNA elements of 
varying quantity, length and position within the tar-
get transcript. The mean background corrected signal 
intensity was measured for each β-actin and GAPDH control 
element on a microarray hybridised with labelled cDNA 
from ConA stimulated PBLs. (a) Signal reported by β-actin 
(◆) and GAPDH (■) elements as a function of the quantity 
of spotted DNA. The error bars denote one standard devia-
tion of the mean. (b) Signal reported by β-actin (◆) and 
GAPDH (■) elements with DNA lengths ranging from 200 
to 1500 bp. (c) Signals reported by β-actin (black) and 
GAPDH (unshaded) elements of constant DNA length but 
positioned at the 3'-end, mid-region or 5'-end of the respec-
tive target transcripts.Page 4 of 22
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ever, the signal intensity reported from the β-actin control
elements increases as the length of the element DNA
increased. The shorter 200 and 500 bp fragments contain
DNA corresponding to the 3'-UTR of the bovine β-actin
gene, whilst the longer control elements include part of
the coding region of the β-actin transcript. Therefore, the
increased signal reported from the longer elements may
be due to an increasing proportion of cross-hybridisation
with other members of the actin superfamily, which will
bind to the more conserved region of the element DNA.
The elements printed on the Bovine Innate Immune
Microarray are a mixture of cDNAs from both the 3' and
5' end of the expressed transcript. To explore the effect this
may cause on the reported signal, distinct 400–500 bp ele-
ments from the 3'-end, middle and 5'-end of the bovine β-
actin and GAPDH transcripts were used as positional con-
trols. These elements were printed at a constant concentra-
tion of 200 pg/spot. The labelled cDNA from ConA-
stimulated bovine PBLs was produced using both oligo-
dT and random hexamer priming. Figure 2(c) demon-
strates that the signals for both the β-actin and GAPDH
control elements are independent of the position of spot-
ted DNA with respect to the target transcript. Therefore, by
using both random hexamer and oligo-dT to generate the
labelled cDNA targets, there is no discernible bias
between elements from the 3' or 5' ends of the target
transcripts.
Microarray reproducibility
Six microarrays hybridised with replicate cDNA samples
were used to study slide-to-slide data reproducibility. The
variation introduced by using different microarray slides
for each hybridisation was determined by calculating the
correlation of signal ratio between each slide. cDNAs from
ConA stimulated PBLs and unstimulated PBLs were
labelled with either Cy3 or Cy5 and hybridised to six inde-
pendent microarray slides (Fig. 3(a)). An example of the
correlation of signal ratio between two slides is presented
in figure 3(b). For each element, the signal ratio was cal-
culated by comparing the signal from ConA stimulated
PBLs to the signal from unstimulated PBLs. The reproduc-
ibility of the signal ratio was determined by calculating
the correlation co-efficient between data from each micro-
array in a pair-wise manner (Table 2). The mean correla-
tion co-efficient was 0.88. The reproducibility of the
signal ratio increases to a correlation co-efficient of 0.93,
when comparing data from slides with the same dye
orientation.
Microarray limit of detection
The Lucidea Universal Scorecard RNA mix (Amersham
Bioscience, UK) was included on one slide to assess the
limit of detection of the Bovine Innate Immune
Microarray. The Lucidea RNA mix contains specific tran-
scripts in a range of concentrations. The Lucidea RNA mix
(4 µl) was added to sample total RNA (20 µg) to produce
a concentration gradient of 0.1, 0.3, 1, 3, 10, 30, 100,
1000 and 3000 pg of Lucidea transcripts per µg of sample
RNA. Each Lucidea transcript bound to a specific Lucidea
calibration control element present on the microarray.
The limit of detection of the microarray was then deter-
mined in pg of Lucidea transcript per µg of total RNA. The
Slide to slide reproducibility of the Bovine Innate Immune MicroarrayF gure 3
Slide to slide reproducibility of the Bovine Innate 
Immune Microarray. (a) Schematic diagram of the experi-
mental design. Each arrow represents one microarray slide 
with the arrow direction indicating the cDNA labelling from 
Cy5 to Cy3-labelled cDNA. Bovine PBLs were cultured for 
24 h with or without ConA (5 µg/ml). (b) An example of 
slide-to-slide reproducibility depicted as a scatter plot of the 
signal ratio on slide 1 vs slide 3. The signal ratio was calcu-
lated by dividing the background corrected signal for ConA 
stimulated PBLs by the background corrected signal for 
unstimulated PBLs.Page 5 of 22
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labelling reactions to determine whether there is any dif-
ference in hybridisation sensitivity between the two Cy
dyes.
The signal reported from each of the Lucidea calibration
control elements was averaged across replicates (Fig. 4).
The Lucidea transcript present at a concentration of 0.1
pg/µg of total RNA, had a detectable log2 signal of 6.83 ±
0.24 in the Cy5 channel and 8.93 ± 0.40 in the Cy3
channel when hybridised to the microarray. At a concen-
tration of 1 pg/µg of total RNA, transcripts showed no sig-
nal intensity differences between the Cy3 and Cy5 dye
channels. Therefore, we have set the limit of detection of
the Bovine Innate Immune Microarray at 1 pg/µg of sam-
ple total RNA, as this is the lowest detectable starting
template which produces a reliable signal, independent of
Cy dye label.
Analysis of the time course of activation of PBLs with ConA
Labelled cDNAs were generated from bovine PBLs that
had been cultured with 5 µg/µl ConA for time periods of
0, 0.5, 2, 4, 8 or 24 h. cDNA produced from the bovine
PBLs collected at each time point was used in a hybridisa-
tion mix with cDNA from unstimulated cells. A dye swap
microarray was also included for each sample (Fig. 5(a)).
An MA plot is used to depict the Cy5:Cy3 signal ratio (M
= log2 [Cy5/Cy3]) and total signal intensity (A = 1/2 *
([log2 Cy5]+[log2Cy3])) for each spot on the microarray
[30]. Figure 5(b) depicts the MA plots for the five micro-
array slides hybridised with Cy5-labelled cDNA from
stimulated PBLs and Cy3-labelled cDNA from unstimu-
lated cells (MA plots for the dye swap experiments are not
shown). The MA plots show an increase in the differences
of gene expression between the stimulated/unstimulated
samples as the time course progresses. In this example,
elements which have a signal ratio above zero have greater
signal intensity (and therefore higher transcript abun-
dance) in the ConA-activated sample compared to the
unstimulated sample. As the time course progressed, an
increasing number of elements were showing higher tran-
script abundances in the cDNA from ConA-activated
Table 2: Correlation coefficients of the signal ratio1 data sets reported from six replicate micrroarrays2
ConA-Cy3 ConA-Cy5
Slide 1 Slide 2 Slide 3 Slide 4 Slide 5 Slide 6
ConA-Cy3 Slide 1 1
Slide 2 0.919 1
Slide 3 0.943 0.924 1
ConA-Cy5 Slide 4 0.828 0.800 0.847 1
Slide 5 0.896 0.870 0.909 0.933 1
Slide 6 0.806 0.789 0.840 0.929 0.920 1
Average Ratio Correlation (all data) 0.88
Average Ratio Correlation (ConA = Cy3) 0.93
Average Ratio Correlation (ConA = Cy5) 0.93
1 The signal ratio was calculated by dividing ConA signal divided by Unstimulated signal for each element
2 The schematic diagram of experimental design is depicted in figure 3
Estimation of the limit of signal detection for the Bovine Innate Immune MicroarrayFigure 4
Estimation of the limit of signal detection for the 
Bovine Innate Immune Microarray. The Lucidea Uni-
versal RNA mix was used in both Cy3 and Cy5 labelling reac-
tions with specific transcripts present at a concentration 
range of 0.1 to 3000 pg per µg of total sample RNA. The 
mean background corrected signal, reported from each cor-
responding Lucidea Calibration control element printed on 
the microarray is plotted as log2 (signal) in Cy3 (■) and Cy5 
(◆) dye channels. Error bars represent one standard devia-
tion from the mean.Page 6 of 22
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showing decreased transcript abundance in the ConA
treated sample.
A mixed model ANOVA analysis of the data revealed that
252 (4.3%) of the microarray elements were differentially
expressed in response to ConA and the sensitivity of this
experiment was calculated to be 80 transcripts per million
by the method described in Reverter et al. (2005) [31].
This level of sensitivity is in the same range as SAGE gene
expression data. Annotation of the differentially expressed
gene list, including sequencing of the relevant clones from
the anonymous cDNA libraries, found that the 252 ele-
ments represented 105 non-redundant transcripts (Fig. 6).
Using the default K-means clustering analysis in Gene-
Spring 6.1 software, (Silicon Genetics, Redwood City, CA,
USA) the differentially expressed elements were grouped
into 10 primary clusters (data not shown). Several of the
primary clusters were very similar and contained clones of
the same gene. Consequently, the primary clusters were
condensed by grouping clusters with similar expression
patterns into three basic profiles. As shown in figure 6 the
first cluster, Induction 1, represents 19 transcripts that
were up-regulated within 30 minutes of stimulation with
ConA but which returned to the base line by 24 h. Induc-
tion 2 (76 transcripts) represents transcripts that were up-
regulated in response to ConA, with an expression peak at
8 h and sustained expression levels until 24 h. The final
cluster, Suppression 1, represents 10 transcripts which are
down-regulated in response to ConA.
The Induction 2 cluster of differentially expressed genes
contains 76 genes and is the largest of the three clusters.
Nine of those genes encode chemokine ligands or recep-
tors. A number of secreted growth factors and cytokines
were also present in this group (ie CSF1, IFNG, LTA). The
cluster also contains 11 heat shock related proteins (chap-
eronins) and 11 transcription factors. Six genes in the
same expression profile are involved in regulating differ-
entiation and apoptosis while a further 8 genes are
involved in intracellular signalling or cell cycling.
The 19 genes in Induction 1, which are up-regulated early,
include components of the Toll signalling pathway
(TRAF1, TRAF5, NFKBIA), the TNF axis (TNF, TNFRSF18)
and genes regulating phosphorylation switches (DUSP1,
DUSP2, ZAP70 and INPP1). Up-regulation of several tran-
scription factors was also observed (REL, MYC, NR4A1,
NR4A3, EGR1, EGR2, JUN) as well as mRNA for the
glycoprotein CD69, which is a cellular marker for early
activation of lymphocytes.
The majority of genes identified as being differentially
expressed (95/105) were more abundant in PBLs
stimulated with ConA. However, ten transcripts were
down-regulated (Suppression 1) including 4 that encode
extracellular matrix proteins (THBS, ITGA5, M160,
CSRCR) and 2 genes involved in G-protein signalling
(RASGRP2 and RGS14).
qRT-PCR validation of microarray expression profiles
Quantitative real-time RT-PCR (qRT-PCR) was used to
independently evaluate the differential expression profile
of representative genes from each of the three main pro-
files. The same total RNA samples were used in both the
microarray and qRT-PCR assays to accurately validate the
data which was generated using the microarray. Assays
were designed for tumour necrosis factor alpha (TNF),
interferon gamma (IFNG), chemokine (C-C motif) ligand
3-like 1 (CCL3L1), interleukin 2 receptor alpha (IL2RA),
tumor necrosis factor receptor super family member 9
(TNFRSF9) and thrombospondin (THBS). qRT-PCR
assays were also performed for the reference genes, acidic
ribosomal protein large P0 (RPLPO) and Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH). Primer informa-
tion is listed in Table 3. To compare the data generated by
microarray analysis with data from qRT-PCR, the qRT-
PCR data was first normalised to the reference gene
RPLPO, then the log2 (fold change) was calculated for
each time point relative to the gene expression in unstim-
ulated cells.
Figure 7 depicts the log2 (fold change) calculated from
both microarray data and qRT-PCR data for TNF,
TNFRSF9, IL2RA, CCL3L1 and THBS. Each plot shows a
similar pattern of gene expression across the time course,
for both the microarray and qRT-PCR data. However, the
log2 (fold change) calculated by qRT-PCR consistently
shows a greater magnitude of change compared to the
microarray data. This may be due to the larger dynamic
range of signal intensities that can be detected using qRT-
PCR [32].
TNF was selected as a representative of the Induction 1
profile. The qRT-PCR data accurately corresponds to the
general profile calculated for this cluster using the
microarray data, i.e. transcript expression levels were
markedly increased after 30 minutes of ConA stimulation
and the gene expression level had almost returned to the
basal level by 24 h. TNFRSF9, IL2RA and CCL3L1 repre-
sent elements from the Induction 2 profile. Again the qRT-
PCR data confirm the gene expression profile deduced
from the microarray data. These transcripts were up-regu-
lated by 2–4 h, gene expression peaked at 8 h and was sus-
tained until the 24 h time point. However, the expression
of CCL3L1 returned to base levels at 24 h.
THBS represents elements of Suppression 1 where tran-
script expression levels are down- regulated in response toPage 7 of 22
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BMC Genomics 2005, 6:135 http://www.biomedcentral.com/1471-2164/6/135Time course of ConA activation of bovine peripheral blood lymphocytesF gure 5
Time course of ConA activation of bovine peripheral blood lymphocytes. (a) Schematic diagram of the experimental 
design. Each arrow represents one microarray slide with the arrow direction indicating the cDNA labelling from Cy5 to Cy3-
label. Bovine PBLs were stimulated with ConA (5 µg/ml) for 0.5, 2, 4, 8 or 24 h. cDNA from the treated cells were compared 
to cDNA from unstimulated cells. (b) MA plots of microarray data from the ConA activation time course (dye swap replicates 
are not shown). Labelled cDNA from bovine PBLs treated with ConA (Cy5) were compared to labelled cDNA from unstimu-
lated cells (Cy3). The X-axis shows the total signal intensity for each element present on the microarray (calculated as 1/
2*((log2(Cy5) + log2(Cy3))). Y-axis shows the log2 (signal ratio) (log2(Cy5/Cy3)). Elements with a log2 (signal ratio) greater than 
zero represent transcripts which are more abundant in the ConA activated PBL sample.Page 8 of 22
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BMC Genomics 2005, 6:135 http://www.biomedcentral.com/1471-2164/6/135Clusters of differentially expressed genes from PBLs stimulated with ConAFigure 6
Clusters of differentially expressed genes from PBLs stimulated with ConA. 252 elements representing 109 unique 
transcripts were found to be differentially expressed in bovine PBLs during the time course of ConA stimulation. Ten primary 
K-means clusters were grouped according to similarity into three general profiles; Induction 1, Induction 2, and Suppression 1. 
These are depicted by the average signal from the elements within the cluster. Y-axis is the background corrected mean signal. 
The gene symbol for each transcript within the cluster is listed.
Table 3: Oligonucleotide primer sequences for qRT-PCR validation of microarray results
Gene name (Symbol) Accession 
number
Forward Reverse Amplicon size 
(bp)
Acidic Ribosomal Protein 
Large P0 (RPLP0)
NM_001012682 CAACCCTGAAGTGCTTGACAT AGGCAGATGGATCAGCCA 220
Glyceraldehyde-3-Phosphate 
Dehydrogenase (GAPDH)
AF077815 CCTGGAGAAACCTGCCAAGT GCCAAATTCATTGTCGTACCA 226
Tumour Necrosis Factor 
alpha (TNF)
NM_173966 CTGGTTCAGACACTCAGGTCCT GAGGTAAAGCCCGTCAGCA 183
Interferon gamma (IFNG) NM_174086 GTGGGCCTCTCTTCTCAGAA GATCATCCACCGGAATTTGA 234
Chemokine (C-C motif) 
ligand 3-like 1 (CCL3L1)
NM_174511 GGTCTTCTCGGCACCATTT CCAGGTCGGTGATGTATTCC 209
Interleukin 2 receptor alpha 
(IL2RA)
NM_174358 ACCATGATAAACTGCGACTGC GGTTGGTAAGAAAGTTCCACTCC 513
Tumor Necrosis Factor 
Receptor Super Family 
Member 9 (TNFRSF9)
NM_001561 AAATCCTGCAGTGATCGTGTCC CTTCTTCAGCAGCCCTGGAAT 189
Thrombospondin (THBS) NM_174196.1 CCAATCCTGACCAGAAGGAC TGGCGTACAACCCAGTTAGG 202Page 9 of 22
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of expression. The log2 (fold change) calculated from the
microarray data is sustained at a level of -2 at 24 h, while
the log2 (fold change) calculated from the qRT-PCR data
indicates that THBS expression continues to decline at 24
h. The reason for this difference is not clear but could be
due to the greater sensitivity of qRT-PCR.
Validation of gene expression profiles by quantitative real time RT-PCR (qRT-PCR)Figure 7
Validation of gene expression profiles by quantitative real time RT-PCR (qRT-PCR). The three gene expression 
profiles discovered by microarray analysis were validated by qRT-PCR with genes representative of each cluster. The log2 (fold 
change) was calculated for both microarray data (◆) and qRT-PCR data (■) at each treatment time point relative to that in 
unstimulated cells. TNF represents the gene expression profile of Induction 1; TNFRSF9, IL2RA and CCL3L1 represent the Induc-
tion 2 profile and THBS represents the Suppression 1 profile.Page 10 of 22
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To determine the hybridisation efficiency of ovine tran-
scripts to the Bovine Innate Immune Microarray, a direct
comparison of gene expression in equivalent ovine and
bovine samples was undertaken. PBLs were extracted from
each species. The cells were then cultured for 24 h without
stimulation, to avoid any expression differences which
may occur due to different species-specific responses to
ConA. Ovine, bovine and a 50:50 mixture of ovine and
bovine labelled cDNA were applied to the Bovine Innate
Immune Microarray in an All Pairs design using dye swaps
for each comparison (Fig. 8(a)).
Labelled cDNA from the bovine sample produced signifi-
cant signal from 9010 elements (56% of the microarray),
while labelled cDNA from the ovine sample produced sig-
nificant signal from 8444 elements (52% of the microar-
ray). Assuming that the same repertoire of genes is
expressed in both species, then the Bovine Innate Immune
Microarray detects 94% of the transcripts from unstimu-
lated ovine PBLs. However, only one animal from each
species was examined in this experiment, more biological
replicates of each species will be required before
assumptions can be made regarding species specific gene
expression differences.
Figure 8(b) depicts the signal correlation between bovine
cDNA labelled with Cy3 and Cy5 (Upper Panel), ovine
cDNA labelled with Cy3 and Cy5 (Middle Panel) and
bovine labelled cDNA and ovine labelled cDNA (Lower
Panel). The correlation coefficients of the signals from a
hybridisation using only bovine or only ovine cDNAs are
0.95 and 0.92, respectively. The correlation coefficient for
the ovine and bovine comparison is 0.87. Therefore, the
ovine genes being detected by the microarray have a very
similar relative expression pattern to the corresponding
bovine genes.
Discussion
The Bovine Innate Immune Microarray was constructed
using the wealth of information pertaining to innate
immune related genes from the mouse, human, bovine
and ovine literature and complementing this with
anonymous genes derived from bovine cells that were
'challenged' to produce innate immune responses. Taking
into account the level of redundancy across the cDNA
libraries the microarray contains up to 5400 unique
bovine genes. Therefore, the microarray should have the
potential to identify pathways in bovine cells and tissues
activated by a range of immune stimuli. There is also a
growing body of evidence that implicates many immune-
related genes in normal physiological processes eg. tissue
remodelling [33]. The microarray may therefore have
wider applications in assessing changes in gene expression
accompanying natural physiological and developmental
Cross-species hybridisation of an ovine sample to the Bovine Innate Immune MicroarrayFigure 8
Cross-species hybridisation of an ovine sample to the 
Bovine Innate Immune Microarray. (a) Schematic dia-
gram of the experiment which used unstimulated ovine and 
bovine PBLs cultured for 24 h. Each arrow represents one 
microarray slide where the arrow direction indicates the 
cDNA labelling from Cy5 to Cy3-label. (b) Scatter plots of 
microarray data as log2 (signal). The upper and middle panels 
show the variation observed when comparing signals from an 
identical cDNA source which was labelled with both Cy3 and 
Cy5 dye; bovine/bovine (upper panel) and ovine/ovine (mid-
dle panel). The lower panel shows a scatter plot of the log2 
(signal) from ovine PBL cDNA compared to the log2 (signal) 
from bovine PBL cDNA.Page 11 of 22
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provides useful tools to assess the reproducibility and
sensitivity of the microarray, two of the generally limiting
factors of this technology.
The reproducibility of the microarray was ascertained by
comparing samples from bovine PBLs with ConA
activated PBLs using replicates and dye swaps. The raw sig-
nals and signal ratios reported from six independent
microarrays were highly reproducible. The average corre-
lation co-efficient of the signal ratio across the six micro-
arrays was 87.7%. Therefore the slide-to-slide
reproducibility of the Bovine Innate Immune Microarray
is high. The lower limit of signal detection on the Bovine
Innate Immune Microarray was measured using 'spike in'
RNA transcripts of known quantities from the commercial
Lucidea Microarray Scorecard (Amersham Biosciences).
This allowed calculation of an empirical lower limit of
detection of 1 pg/µg of total RNA.
Interpretation of transcript profiling data assumes that
changes in mRNA expression are mirrored by
corresponding changes in encoded protein quantity and
therefore activity. While this may not always be true it is
reasonable to expect this for the many genes particularly
with immune related functions which require rapid
responses of cells to external stimuli and their rapid return
to a resting state in the absence of the stimuli. A number
of studies have also shown significant correlation between
mRNA and protein expression levels [34,35].
A number of alternative transcript profiling techniques
such as EST frequency analysis, Massive Parallel Signature
Sequencing (MPSS) [36] and Serial Analysis of Gene
Expression (SAGE) [37,38] have potential for much
greater depth of coverage compared with microarrays. The
former techniques reveal that in most tissues and cells the
majority of transcripts are expressed at low levels. Thus,
these techniques can provide information on the abun-
dance of transcripts expressed below the sensitivity limit
of a microarray, the inference being that microarrays
report the transcriptional activities of components of
pathways but not the entire pathway or gene network. EST
frequency analysis, MPSS and SAGE however, have other
limitations such as relative high cost and low sample
throughput. Microarray technology provides a compro-
mise that allows assessment of activated gene pathways in
the context of relatively large numbers of samples.
The Bovine Innate Immune Microarray is also suitable for
use with ovine samples. The relatively high sequence iden-
tity of ovine and bovine orthologous transcripts (mean
identity of 96 ± 2.4%)[23] and the use of long cDNAs on
the microarray underlie this ability. Intriguingly, cross-
species microarrays investigating gene expression in com-
parable tissues may reveal species-specific differences that
underlie functional differences. The functional differences
in the innate immune responses of comparable tissues in
related species are likely to be the result of subtle quanti-
tative differences in large numbers of genes that contrib-
ute to the dynamic balance in the overall system. These
differences may be ascertained by screening a population
of animals from each species.
The power of a microarray can be enhanced by the exper-
imental design [39]. Inclusion of a time course or dose
response also enhances the ability of microarray data to
identify differentially expressed genes and provides a
means to cluster genes behaving in a concordant manner.
Microarray analysis was performed on bovine PBLs that
had been subjected to activation with ConA over a 24 h
period. Analysis of the time course data has identified
three major clusters of differentially expressed genes. The
challenge is to link groups of genes in these clusters with
the known physiological outcomes of lymphocyte activa-
tion i.e. secretion of intercellular signalling proteins such
as cytokines, chemokines and growth factors, activation of
intracellular signalling cascades, cytoskeletal, cell surface
and extracellular matrix reorganisation, apoptosis and
proliferation. Clearly, the approach is to use known infor-
mation pertaining to human and murine innate immune
pathways to allow an understanding of the pathways acti-
vated in bovine cells. Hence, the following discussion has
utilised existing information pertaining to murine and
human genes to enable interpretation of the data from the
bovine PBLs activated with ConA.
Induction 1
TNF axis and Toll pathway
The first cluster, Induction 1, contains genes that were rap-
idly up-regulated within 30 minutes of stimulation with
ConA and subsequently returned to their basal levels at 24
h. This cluster contained 19 transcripts including TNF, a
potent extracellular signalling factor that is a pivotal
proinflammatory cytokine as well as a multifunctional
protein regulating cell proliferation, differentiation and
apoptosis)[40]. The cluster encodes components of
intracellular signalling pathways known to be involved in
responses of cells to immune challenges. In particular, the
TNF Receptor Associated Factors, TRAF1, TRAF2 and
TNFRSF18 associate with the TNF receptor superfamily.
TRAF1 and TRAF2 regulate gene expression in activated
lymphocytes by mediating signal transduction from TNF
receptors via MAPK8/JNK and NF-κB pathway [41].
TNFRSF18 has been implicated in anti-apoptotic signals
via TRAF2, which is thought to be involved in protection
of lymphocytes against activation-induced cell death
[42,43]. NFKBIA, an inhibitor of NF-κB, was also present
in the cluster suggesting that after only 30 minutes stimu-
lation of the PBLs with ConA, homeostatic mechanismsPage 12 of 22
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this time may be an important mechanism that returns
the expression levels of the genes in this cluster to basal
levels at 24 h.
Phosphorylation switches
DUSP1 and 2, Dual Specificity Phosphatases 1 and 2, can
reverse MAP kinase activation by dephosphorylating
phosphotyrosine and phosphothreonine residues [44].
MAP kinase is a central regulatory component of a cascade
of signalling proteins that ultimately leads to the activa-
tion of many transcription factors [44]. DUSP1 and 2 are
also probably dampening the overall stimulatory
response and may be contributing to the homeostasis
characteristic of this cluster. ZAP70, a protein tyrosine
kinase, is associated with the T-cell receptor and plays a
key role in NF-κB activation within T-cells [41]. Clearly
the changes in the expression levels of DUSP1 and
DUSP2, ZAP70 and INPP1 (Inositol Polyphosphate-1-
Phosphatase) are consistent with the phosphorylation
switches that are known to underlie activation of many of
the pathways in activated lymphocytes [45].
Transcription factors
A number of transcription factors are also components of
this cluster and these are likely to orchestrate the changes
in gene expression that accompany activation of PBLs.
This group includes REL, MYC, NR4A1, NR4A3, EGR1,
EGR2 and JUN. REL encodes a subunit of the NF-κB com-
plex that controls the expression of a wide range of
cytokines and other genes associated with lymphocyte
activation [41]. NR4A1 (Nuclear Receptor subfamily 4,
group A, member 1) has similarities to the steroid and
thyroid hormone receptor families and has been impli-
cated as a regulator of apoptosis in murine thymocytes
[46]. The expression of this gene in murine macrophages
has been reported to show rapid but transient induction
by several mitogens [47], a response identical to that
described for this cluster. The role of the related gene
NR4A3 is not clear. EGR1 and EGR2 in murine lym-
phocytes are also induced by mitogenic stimuli but their
precise functional roles are not well defined [48].
Interestingly, the transcription factors JUN and FOS coop-
erate in promoting gene transcription and both EGR1 and
EGR2 have structural and functional similarities with FOS
[49]. The latter gene is a member of the Suppression 1
cluster and is down-regulated during ConA mediated PBL
activation. These observations suggest that the JUN/FOS
axis of the MAP kinase pathway is a key regulatory point
in bovine lymphocyte activation by ConA.
Glycoprotein
CD69, another member of this cluster, is one of the earli-
est inducible cell surface glycoproteins during murine
lymphoid activation and is involved in regulating lym-
phocyte proliferation [50].
In summary, the genes in the Induction 1 cluster are
largely regulatory in function (with the exception of TNF
which can be classed as an intercellular effector) with
many involved in controlling lymphocyte activation,
apoptosis and gene expression. Some of these genes may
be over-expressed at this early time point to limit the acti-
vation response and prevent over-stimulation of the PBLs,
with consequent detrimental effects on themselves as well
as by-stander cells.
Induction 2
The Induction 2 cluster (76 transcripts) is markedly up-
regulated and sustained at 24 hours of stimulation with
ConA. A number of strong functional themes are evident
in this cluster.
Cytokines
The first theme pertains to a group that encodes three plei-
otropic and very potent cytokines, CSF1 (Colony Stimu-
lating Factor 1), IFNG (Interferon γ) and LTA
(Lymphotoxin α precursor; or TNFβ). These proteins
mediate a wide range of immuno-stimulatory, differentia-
tion and proliferative responses of immune cells and are
key effector outputs from activated lymphocytes [51]. LTA
may also have a role in apoptosis through the TNFR-asso-
ciated death domain pathway)[40].
Chemokines
Chemokines are major effectors secreted from activated
lymphocytes. This group consists of chemokine ligands
CCL1, CCL20, CCL3, CCL3L1, CCL4L, CXCL10 and three
chemokine receptors, IL2RA, CCR4 and BLR1. Chemok-
ines are typically chemo-attractants that regulate cell traf-
ficking and have fundamental immuno-regulatory roles
including involvement in inflammatory processes [51].
Heat shock related
The heat shock related proteins (chaperonins) may be
required to facilitate correct protein folding in the tran-
scriptionally activated PBLs or to stimulate NF-κB via the
Toll-like receptors [52]. Genes such as HSPD1, HSPA4 and
HSPA8 have been directly implicated in innate immune
responses of immune cells [52].
Intracellular signalling
The fourth group consists of six genes that have a role in
intracellular signalling (RGS1, GBP1, GBP3, GBP5, DUSP5
and PTPN11). RGS1 (Regulator of G-protein Signalling 1)
is a regulator of G-protein signalling and may play a role
in attenuation of the RAS mediated signal that promotes
PBL activation. GBP1, 3 and 5 are IFNG induced guanylate
binding proteins [53]. Although their exact roles arePage 13 of 22
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signalling pathway. DUSP5 (Dual specificity phosphatase
5) inactivates members of the Mitogen Activated Protein
Kinase (MAPK) family that promote lymphocyte activa-
tion via NF-κB and therefore may be involved in attenua-
tion of this signal. Although PTPN11 (Protein tyrosine
Phosphatase Non-Receptor type) also regulates the activ-
ity of the MAPK pathway it is not known whether this pro-
motes or inhibits the pathway [54].
Differentiation and apoptosis regulators
Another group of genes may also be classed as intracellu-
lar signalling factors but have additional, specific roles in
regulating differentiation and apoptosis [55]. This group
consists of GADD45B, CFLAR, CASP7, BCL2, BCL2A1 and
IER3. Presumably the function of the proteins encoded by
these genes is to maintain the dynamic balance between
cell proliferation, differentiation and apoptosis. Many of
these genes are induced in stressed or activated immune
cells.
Nuclear proteins
A number of genes have been identified that encodes
nuclear proteins that play a role in maintenance of the
nuclear lamina (LMNB1), bind to the nuclear matrix
(SRRM1) or are involved in the assembly of ribosomes
(NPM1 and NCL), suggesting major alterations in the
organisation and function of the nucleus of activated cells
[56]. Consistent with this there was also over-expression
of a histone (H2AFZ) and a histone deacetylase (HDAC5)
in this group.
Transcription factors
A functionally diverse array of 11 transcription factors are
represented in this cluster (TRIP12, HIF1A, BATF, APEX1,
ATF3, CEBPG, IRF1, SLAMF1, PARK7, RAN, RBM13 and
NFKB1). Notable amongst these is NFKB1 a pivotal tran-
scription factor regulating the expression of a large
number of immune related genes (see above) and CEBPG
which cooperates with FOS to regulate the transcription of
genes containing PRE-1 enhancer elements [41,57]. (see
the earlier discussion on FOS). Clearly the ConA activated
lymphocytes have enhanced transcriptional activity and
this, in conjunction with increases in the chaperonins, is
consistent with an enhanced role in the production of
secreted cytokines and chemokines, the primary effectors
secreted from these cells.
Cell surface proteins
This cluster also contains a group of genes encoding pro-
teins bound to the cell surface (ICOS, SCARB1, SLAMF1,
ANXA9, C1QBP and CD53). Three of these genes, ICOS,
SLAMF1 and CD53 encode proteins that play important
roles in cell-cell signalling and the regulation of cell pro-
liferation suggesting that they may reflect the induction of
proliferation in the ConA activated PBLs [58].
Suppression 1
Extracellular matrix
There are relatively few genes in the Suppression 1 cluster
but one theme is the suppression of extracellular matrix
proteins involved in anchoring cells to other cells and to
the extracellular matrix. This is consistent with the induc-
tion of a proliferative response in activated PBLs. The pro-
teins encoded by these genes include: THBS
(Thrombospondin), an adhesive glycoprotein mediating
cell-cell and cell-matrix interactions; ITGA5 (Integrin
Alpha chain A5), an adhesive component of the extracel-
lular matrix; and M160 (CD163 Antigen B), a member of
the scavenger receptor (SRCR) superfamily.
Signalling
A second theme relates to the suppression of two genes
whose encoded proteins are involved in G-protein signal-
ling. RASGRP2 (RAS guanyl releasing protein 2 isoform 1)
activates small GTPases involved in intracellular signal
transduction such as RAS and its counter regulatory factor
RAP1 [59]. The latter two proteins are components of the
MAPK pathway, which is intimately involved in lym-
phocyte activation [44]. Suppression of RASGRP2 may be
attenuating the RAS signalling pathway and hence lym-
phocyte activation (i.e. promoting homeostasis) by
directly decreasing the activity of RAS or by activating
RAP1 which in turn inhibits RAS. Consistent with this
RGS14 (Regulator of G-protein Signalling 14) attenuates
the signalling activity of G-proteins such as RAS [60].
Apoptosis regulator
This cluster also contains IL7R (Interleukin 7 Receptor)
whose functions involve the inhibition of apoptosis dur-
ing differentiation and activation of lymphocytes. The
suppression of the expression of this gene may be facilitat-
ing apoptosis in the activated PBLs.
Overall, the differentially expressed genes in ConA acti-
vated bovine PBLs reflect the emphasis on the expression
of a range of secreted intercellular signalling proteins,
which are regulated by a dynamic balance between
intracellular proteins promoting activation and prolifera-
tion and those that modulate or attenuate this process.
Many of the genes identified in the clusters have also been
noted as inducible genes in murine and human immune
cells thereby attesting to the functional similarities of the
immune systems of mammalian species and the capabili-
ties of the microarray.
In conclusion, the Bovine Innate Immune Microarray has
revealed details of the many gene networks that are acti-
vated in a model of bovine lymphocyte activation and itPage 14 of 22
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immune responses in bovine and ovine tissues challenged
with bacteria (eg. mastitis), parasites (eg. intestinal
Helminths) and a wide range of viruses. The microarray
also has the potential for examining the roles of innate
immune related genes in normal physiological processes
such as the tissue remodelling occurring during mammary
tissue involution.
Methods
Generation of the Bovine Innate Immune Microarray
DNA probes printed on the Bovine Innate Immune Micro-
array came from two main sources: innate immune candi-
date genes identified from the literature and anonymous
cDNA clones generated by subtractive normalisation of
transcripts from a variety of 'challenged' bovine cells.
(i) Selection of innate immune candidate genes
An extensive search of the human, mouse and bovine
immunobiology literature and databases was undertaken
to create a set of well characterised candidate genes based
on their function and evidence of expression during
immune responses [61-64]. Plasmid clones correspond-
ing to some of the candidate genes were identified in
available cDNA libraries including: Meat Animal Research
Center (MARC) 1–5 libraries [25,26]; and in-house ovine
and bovine cDNA libraries that had been used for the pro-
duction of ESTs [27,28]. (see Additional file 1). Selected
clones were streaked on LB agar plates (100 µg/ml Ampi-
cillin) and grown overnight at 37°C. Individual colonies
from each clone were transferred into wells of 96-well
plates containing 200 µl Terrific broth (12 g/l bacto-tryp-
tone, 24 g/l bacto-yeast extract, 0.4% glycerol, 17 mM
KH2PO4, 72 mM K2HPO4, 100 µg/ml Ampicillin) and
grown overnight at 37°C. Replicates of the libraries were
made from the overnight cultures and both replicate and
master plates were stored in 40% glycerol at -80°C. Plas-
mid cDNA clones were not available for all of the selected
candidate genes and therefore gene-specific primers were
designed based on publicly available bovine, ovine and/
or human sequences. If no bovine or ovine sequence
information was available primers were designed in areas
that were conserved across known mammalian species.
Primer design and optimisation were carried out using
Primer 3 [65]. Primer information is listed in Additional
file 2. Database searches, alignments and sequence analy-
ses were performed with the aid of the ANGIS [66], NCBI
[67] and IBISS [68,69]. databases. Bovine transcripts that
had not been annotated were identified by BLAST
searches against the orthologous human or mouse
sequences [70].
(ii) Cell lines used for subtracted and normalised cDNA libraries
Primary bovine mammary epithelial cells (bMEC) were
kindly donated by Dr Paul Sheehy (Sydney University,
NSW) [21]. An immortalised bovine mammary epithelial
cell line (MAC-T) was provided by Dr Kevin Nicholas
(University of Melbourne, VIC) [71], while an
immortalised bovine macrophage cell line (BoMac) was
donated by Dr Timothy Doran (CSIRO Livestock Indus-
tries, VIC) [72]. Peripheral blood lymphocytes (PBL) were
isolated from blood collected from healthy Hereford cat-
tle and healthy Merino sheep housed at the Queensland
Department of Primary Industries, Animal Research Insti-
tute (Yeerongpilly, Qld). Subtracted and normalised
cDNA libraries were constructed using stimulated and
unstimulated populations of these cell types. Bovine PBL
were stimulated with ConA while bMEC, BoMAC and
MAC-T cell lines were stimulated with LPS.
(iii) Cell culture conditions
bMEC were established on collagen type 1 (calf skin)
(Sigma Chemical Co., St. Louis, MO) in a composite
Medium 199/Hams F12 medium (Invitrogen, Carlsbad,
CA) supplemented with 45 mM sodium bicarbonate, 4
mM sodium acetate, 18 mM Hepes, 20% horse serum, 5%
foetal calf serum (FCS), 100 U/ml penicillin, 100 µg/ml
streptomycin, 100 µg/ml kanamycin (Invitrogen), 500
µg/ml insulin, 100 µg/ml cortisol and 1 µg/ml EGF
(mouse) (Sigma Chemical Co.). MAC-T were cultured in
Dulbecco's modified Eagles's medium (DMEM) supple-
mented with 5% FCS, 100 U/ml penicillin, 100 µg/ml
streptomycin and 100 µg/ml kanamycin (Invitrogen).
BoMac were established on a FCS treated flask in RPMI
1640 supplemented with 10% FCS, 4 mM sodium pyru-
vate, 50 mM HEPES, 100 U/ml penicillin, 100 µg/ml
streptomycin and 100 µg/ml kanamycin (Invitrogen). All
cell lines were cultured at 37°C in a humidified atmos-
phere of 5% CO2.
(iv) Collection and culture of pripheral blood lymphocytes (PBLs)
Peripheral blood lymphocytes from healthy adult Here-
ford cattle were isolated from defibrinated peripheral
whole blood. Briefly, whole blood was centrifuged at 500
g for 30 min at 20°C. The buffy coat was isolated and
layered over a Ficoll-Paque gradient (Amersham Pharma-
cia Biotech, England), followed by centrifugation at 500 g
for 30 min at 20°C. PBLs were collected at the interface
and washed twice in RPMI 1640 (Invitrogen, Carlsbad,
CA) by centrifugation at 500 g for 10 min at 20°C. The
PBLs were resuspended in RPMI 1640 supplemented with
10% FCS, 4 mM sodium pyruvate, 50 mM HEPES, 100 U/
ml penicillin, 100 µg/ml streptomycin and 100 µg/ml
kanamycin (Invitrogen) and cultured in 150 cm2 flasks
(Sarstedt, Nümbrecht, Germany) with or without ConA
(Sigma Chemical Co., St. Louis, MO) at a final concentra-
tion of 5 µg/ml. The cells were harvested for subsequent
RNA extraction after incubation for 24 h.Page 15 of 22
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bMEC, MAC-T and BoMac were cultured in 150 cm2 flasks
(Sarstedt, Nümbrecht, Germany), as previously described,
until 80% confluence. In addition, MAC-T cultures were
grown on collagen type 1 (calf skin) (Sigma Chemical
Co.) in DMEM/10% FCS media supplemented with 500
µg/ml insulin, 100 µg/ml cortisol and 1 µg/ml EGF
(mouse) (Sigma Chemical Co.). All cultures were then
washed once in PBS before subsequent addition of fresh
media with or without LPS (phenol extracted from
Escherichia coli serotype O55:B5; Sigma Chemical Co.
Cat# L2880) at a final concentration of 50 µg/ml. After
incubation of the cells for 24 h, they were washed with
PBS before being harvested using a cell scraper for subse-
quent RNA extraction.
(vi) RNA isolation, cDNA synthesis and cDNA library production
Total RNA was extracted from cells using an RNeasy Midi
Kit (QIAGEN, Basel, Switzerland). The total RNA pre-
pared from each sample was treated twice with DNase I
(on column, QIAGEN DNase I and after elution (Ambion
DNase I)) to minimise the presence of genomic DNA.
mRNA was purified from each sample using a Micro-
Poly(A) Pure mRNA Puification Kit (Ambion). Total RNA
and mRNA was quantified by spectrophotometric meas-
urements at 260 nm and 280 nm and its purity and
integrity verified by the OD260/OD280 ratio (>1.8) and by
visualisation on a denaturing gel. mRNA purity was also
analysed on an Agilent Bioanalyser (Agilent). cDNA
synthesis was undertaken with 2 µg of isolated mRNA per
sample using MMLV Superscript III reverse transcriptase
(Invitrogen) and the Clontech cDNA synthesis primer
from the PCR-Select cDNA Subtraction Kit (Clontech).
The PCR-Select cDNA Subtraction Kit (Clontech) was
used to generate subtracted, normalised cDNA pools for
each of the different cell types and activation states, which
were subsequently cloned into pGEM-T (Invitrogen) and
cultured in XL1-blue E. coli. The cDNA libraries were
grown overnight on LB agar plates (100 µg/ml ampicil-
lin). Colonies were picked at random by hand from each
library and were transferred into wells of 96-well plates
that contained 200 µl Terrific broth and grown overnight
at 37°C. The number of colonies picked from each library
is listed in Table 1. Replicates of the libraries were made
from the overnight cultures and both replicate and master
plates were stored in 40% glycerol at -80°C.
(vii) Validation of subtracted and normalised cDNA libraries
A random selection of 50 clones from each cDNA library
was sequenced to ensure adequate library quality. Clones
were sequenced using M13 universal forward primer and
the ABI Prism® BigDye terminator sequencing mix 3.1
(Applied Biosystems, USA). The ESTs were screened for
vector and E. coli sequence contamination and quality
clipped using the bioinformatic Staden package 'pregap4'
with a cut-off of no more than 10 ambiguous bases in any
window of 100 bases [73,74]. The clipped EST sequences
have been submitted to the Genbank EST database acces-
sion numbers DT319147-DT319651[67]. Annotations
were added to the clipped EST sequences by comparing
them to the Genbank non-redundant and Human RefSeq
nucleotide and amino acid databases using BLASTN and
BLASTX [75,70]. Gene names were assigned to transcripts
only if the Expect score (E-value) confidence limit was less
than e-10. The level of redundancy within each cDNA
library and across the cDNA libraries was also analysed by
comparing the number of unique gene sequences against
the number randomly selected sequenced clones.
(viii) Control elements
A panel of control elements, both positive and negative,
were generated for incorporation into the microarray.
Additional control elements were based on β-actin and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
included size range products, representations of different
regions of these transcripts and different printing quanti-
ties. These elements were used to monitor the efficiency of
printing and to determine if any of the element character-
istics has an effect the fluorescent signal produced by
probe hybridisation. The Lucidea Universal Scorecard
(Amersham Bioscience, UK) was included on the microar-
ray and used to monitor the efficiency of probe produc-
tion, probe hybridisation and microarray scanning.
Details of each product are shown in Table 4. Control ele-
ments were verified by sequencing.
β-actin control elements included a range of fragments of
200, 500, 750, 1000, 1500 and 1900 bp in size, with each
fragment originating from the 3'-end of the transcript.
Three fragments, each of approximately 500 bp, spanning
three independent regions of the β-actin transcript were
also generated. GAPDH elements were similarly generated
including a size range of 200, 580, 750 and 1350 bp and
three fragments of approximately 400 bp representing
unique regions of the transcript.
The control element DNA concentration was monitored
by measuring the absorbance at 260 nm and 280 nm to
achieve a final printing concentration of 200 ng/µl. The
printing concentrations of 500 bp β-actin and GAPDH
fragments (indicated in Table 4) were prepared in a
dynamic range of 25, 50, 100, 200 and 400 ng/µl. There-
fore, each element printed in this range contains 25 – 400
pg of DNA per spot, assuming a pin deposition volume of
1 nl for MicroSpot 2500 pins (Rob Moore, personal
communication).
The Staphylococcus aureus genes, GAPDH and 30S ribosomal
protein S1 were specifically amplified from S. aureus DNA
and included on the microarray. Negative controlPage 16 of 22
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printing buffer, plasmid vector sequence. The plasmid
vector controls include DNA from pGEM-T (Promega,
USA) and pCMVsport6 (Clontech). Flanking vector
sequence amplified in conjunction with cDNA clone
insert sequence was also incorporated as a negative con-
trol element. Sequence information for the all control ele-
ments are shown in Table 4.
(ix) Production of microarray elements
E. coli lysates were prepared by adding 20 µl of overnight
cell culture mix to 180 µl of water followed by heating at
95°C for 15 min. DNA inserts from the MARC cDNA
libraries and the subtracted and normalised cDNA librar-
ies were amplified by adding 5 µl of the cell lysate directly
into PCR master mix (50 µM dNTP, 0.15 µM forward
primer, 0.15 µM reverse primer, 10 mM Tris-HCl (pH
8.3), 50 mM KCl, 1.5 mM MgCl2 and 0.6 U of Taq F2 DNA
polymerase (Fisher Biotech) in a total volume of 65 µl in
96 well plates. MARC1-4.Fwd
(5'AGGAAACAGCTATGACCAT3') and MARC1-4.Rev
(5'GTTTTCCCAGTCACG ACG3') primers were used for
amplification from the MARC cDNA libraries. Clon-
tech.P1 (5'TGCAGCGGCCGCCCGGGCAGGT3') and
Clontech.P2R (5'AGCGTGGTCGCGGCCG AGGT3')
primers were used for amplification from the anonymous
cDNA libraries. Following a pre-heat step of 94°C for 4
min, PCR was performed in a PE 9700 Thermocycler (Per-
kin Elmer) using the following conditions: 94°C for 30 s,
50°C for 30 s and 72°C for 2 min (35 cycles) followed by
94°C for 30 s, 50°C for 30 s and 72°C for 5 min (1 cycle).
A 5 µl sample of each PCR reaction was analysed by agar-
ose gel electrophoresis (96 well gel, BioRad). Greater than
97% of reactions amplified a single PCR product with an
average length of 450 bp. Clones with either no insert or
multiple inserts were also prepared for printing onto the
microarray and the specific elements annotated with this
information. None of the elements containing more than
one PCR product were included in the analyses. Element
DNA was not screened for regions of low complexity or
SINE or LINE elements.
To prepare the amplified cDNA for printing, 60 µl of iso-
propanol was added to each well, the plates were then
inverted 5 times and incubated at -20°C for 10 min. After
the precipitation step, plates were centrifuged at 4500 g
for 60 min, washed with 70% ethanol and air-dried.
Amplicons were resuspended in 20 µl of high purity water
and transferred to one of nineteen 384-well microarray
source plates using a BioMek 2000 liquid handling robot.
An additional 384-well microarray source plate contain-
ing the control elements and the Lucidea Scorecard ele-
ments (Amersham Biosciences, UK) was also produced
for a total of 20 microarray source plates, which were
again allowed to air dry.
(x) Microarray printing
Microarray printing was performed at the Machines for
Genes Laboratory, CSIRO Livestock Industries (Geelong,
Vic). Of the 20 384-well source plates, 19 were printed in
Table 4: Summary of bovine and S. aureus control elements
Control Element Name Reference Accession 
Number3
Start Position (bp) Finish Position (bp)
β-actin 200 AY141970 1675 1804
β-actin 5001 AY141970 1479 1804
β-actin 750 AY141970 1177 1804
β-actin 1000 AY141970 914 1804
β-actin 1500 AY141970 576 1804
β-actin 2000 AY141970 25 1804
β-actin 3'-region2 AY141970 1273 1822
β-actin Mid-region2 AY141970 784 1273
β-actin 5'-region2 AY141970 49 575
GAPDH 200 TC289232 1111 1347
GAPDH 5801 TC289232 771 1347
GAPDH 750 TC289232 575 1347
GAPDH 1350 TC289232 1 1347
GAPDH 3'-region2 TC289232 409 876
GAPDH 5'-region2 TC289232 59 429
S. aureus GAPDH2 NC_002745 832860 833305
S. aureus 30S ribosomal protein2 NC_002745 1513891 1514573
1 Denotes elements printed in a dynamic range of 25, 50 100, 200 and 400 pg per spot. All other elements were printed at 200 pg per spot.
2 Control elements not available in cDNA libraries were amplified using gene specific primers. Primer sequences are listed in Additional file 2.
3 Genbank sequence (AY or NC) or TIGR cluster (TC).Page 17 of 22
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was printed in duplicate at both the top and bottom of
each printed block, giving a total of 16,128 printed ele-
ments. Elements were spotted on Corning UltraGAPS
slides using a BioRobotics MicroGrid II TAS using Micro-
Spot 2500 pins. These pins produce a spot size of approx-
imately 100 µm diameter with a pitch of 220 µm between
spots. Each amplified DNA fragment was printed in dupli-
cate adjacent to each other. The pin configuration was
arranged in 4 columns and 12 rows yielding 48 subarrays
of 19 × 19 spots. Elements were printed in a 150 mM
sodium phosphate printing buffer (pH 8.5). The spots
were then fixed to the slide by baking for two hours at
80°C. To ensure DNA spotting was uniform across the
slides, samples were taken from each batch of microarrays
and probed with Panomer™ 9 random oligodeoxynucle-
otide conjugated with Alexa Fluor® 532 (Molecular
Probes, Invitrogen). Reproducibility was visually assessed
between spot duplicates and between slides within a
printing batch.
cDNA synthesis and labelling
20 µg of total RNA per dye channel per array was reverse
transcribed with Superscript III (Invitrogen) in the pres-
ence of 2-aminoallyl-dUTP (Sigma Chemical Co.) using
both oligo-dT18 (2 µg) and pd(N)6 random hexamer (1
µg) (Amersham Bioscience, UK) to prime cDNA synthesis.
First strand cDNAs were purified using the QIAGEN PCR
purification kit (QIAGEN) and subsequently labelled
using n-hydroxysuccinate (NHS)-derivatized Cy3 and Cy5
dyes (Amersham Biosciences, UK). Labelled cDNAs were
purified to remove unincorporated dyes then dried to
~1.0 µl in a vacuum desiccator.
Microarray hybridisation
Microarray hybridisation was performed essentially as per
Lehnert et al. 2004 with some modifications [76].
Microarray slides were treated in a pre-hybridisation solu-
tion (4 × standard saline citrate (SSC), 0.1% N-lauroyl sar-
cosine (SDS), 50% formamide) for 30 min at room
temperature. Labelled cDNAs were resuspended in 60 µl
(final volume) of hybridisation buffer (15.5 µg Human
CotI DNA (Invitrogen), 20 µg PolyA (Sigma), 4 × SSC,
0.1% SDS, 50% formamide), pre-warmed to 95°C for 3
min then held at 44°C until applied to the slides. Hybrid-
isation was performed in the dark at 44°C for 16 h in
sealed ArrayIt™ Hybridization Cassettes (TeleChem Inter-
national, Inc.) submerged in a waterbath. Following
hybridisation, three washes were applied to the slides: 2 ×
SSC, 0.1% SDS for 15 min, pre-warmed to 44°C; 0.2 ×
SSC for 15 min; and 0.06 × SSC for 5 min. Slides were
washed once in high purity water to remove any remain-
ing salt and dried in a centrifuge at 40 g for 5 min.
Data acquisition
Dried slides were scanned immediately using GenePix™
4000 array scanner. GenePix™Pro software version 5.0
(Axon Instruments Inc.) was then used to process array
images, align spots, integrate robot-spotting files with the
microarray image, and to export reports of spot intensity
data. Slides were visually examined and spots with irregu-
lar morphology were excluded from data analysis. The
final report was retrieved as raw spot intensities in tab-
delimited files, compatible with Microsoft Excel and VCE
analysis programs. Raw data for the microarray experi-
ments reported herein are stored in the GenEx database
and can be accessed on request [77].
Microarray statistical analysis
Statistical analysis of the microarray data was undertaken
using background corrected mean signal intensities from
each dye channel. Raw data were subjected to a series of
quality measures before being included in further analy-
ses. In brief, each data point was required to be flagged
"present" in the GenePix 6.0 software, have a mean to
median signal ratio greater than 0.85 and have a signal to
noise ratio greater than zero. A mixed-model ANOVA was
applied to the data as this type of analysis allows full uti-
lisation of the information available, with multiple factors
and a hierarchy of sources of variation [78-82]. The model
predicts the percentage of differentially expressed ele-
ments by calculating the proportion of variation arising
from the sample treatment, as opposed to the variation
introduced by experimental effects [3]. Restricted maxi-
mum likelihood (REML) estimates of variance compo-
nents and best linear unbiased predictions (BLUP) were
obtained using the VCE software [83]. Differentially
expressed genes were identified using the EMMIX software
for model-based clustering using mixtures of normal
distributions [84,85]. Elements determined to be differen-
tially expressed were further analysed in GeneSpring 6.1
(Silicon Genetics, Redwood City, CA) by a K-means clus-
tering analysis using default parameters.
qRT-PCR validation
Quantitative real-time PCR (qRT-PCR) of selected tran-
scripts was used to validate the expression profile that was
observed in the microarray analyses. Transcripts were
selected as representatives of a cluster showing a specific
expression profile. qRT-PCR was performed using the
same total RNA sample as was used in microarray analysis
to ensure the results from the two technologies could be
compared directly. Primer pairs for each selected
transcript were designed from clone sequences using
Primer3 software as described above. The measurements
were performed using the Sybr Green system in an ABI
Prism 7900 Sequence Detection System (PE Applied Bio-
systems, Foster City, CA) [21]. Briefly, a constant amount
of cDNA (derived from 5 ng of total RNA) was used forPage 18 of 22
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were performed for each gene, one of which was a refer-
ence gene. This allows quantification of the target gene in
one sample relative to that in another (the calibrator)
using the "2-∆∆Ct method" of calculating fold change in
gene expression [86]. The procedure relies on a common
and constant reference gene in all samples. The reference
gene RPLP0 was used for all calculations as it showed no
change in expression upon treatment of cells. For all qRT-
PCR measurements, the abundance of each transcript was
measured relative to that of RPLP0. In order to present the
relative changes in gene expression measured in qRT-PCR
in the same scale as that found in microarray analysis the
quantity of a transcript in one biological sample or state
relative to that in a calibrating sample was expressed as
log2 (fold change) in gene expression. The calibrator used
in this experiment was unstimulated bovine PBLs.
The log2 (fold change) was calculated for both the micro-
array and qRT-PCR data. Microarray data were calculated
as log2 (signal at time t) minus log2 (signal at time 0). qRT-
PCR log2 (fold change) was calculated as Ct time 0 minus
Ct time t, without normalisation against reference genes.
Using this method a log2 (fold change) of 2 is equal to a
doubling of transcript expression relative to the reference
sample, in this case, unstimulated cells.
Microarray reproducibility and sensitivity
Microarray reproducibility was determined by comparing
the signal from six independent slides where the hybridi-
sation samples were identical. PBLs from a healthy adult
Hereford steer (ARI, Yeerongpilly), were isolated and cul-
tured for 24 h both with and without ConA (5 µg/ml).
Total RNA was extracted and 160 µg of RNA from each
treatment was used to produce 2-aminoallyl-labelled
cDNA. Equal amounts of cDNA from each treatment were
labelled with Cy3 and Cy5 to facilitate dye swap
experiments. The hybridisation mixture containing Cy3-
labelled cDNA from ConA stimulated PBLs and Cy5-
labelled cDNA from unstimulated PBLs was split across
three independent slides. The reciprocal hybridisation
mixture was also split across three slides. A schematic dia-
gram of the experimental design is shown in figure 3(a).
The signal ratios of ConA signal/unstimulated signal were
calculated for all elements on each microarray. The corre-
lation co-efficients between the set of signal ratios from
each microarray were determined in a pair-wise manner.
The mean correlation co-efficient was determined and
represents the mean correlation in signal ratios observed
between data from any two microarray slides. The mean
correlation co-efficient was also determined for the three
microarrays hybridised with Cy3-labelled cDNA from
ConA stimulated PBLs and Cy5-labelled cDNA from
unstimulated PBLs, the average correlation was also
determined for the microarrays where the samples were
labelled with opposite dyes.
The Lucidea Universal Scorecard RNA mix (Amersham
Bioscience, UK) was included on one slide to assess the
limit of detection of the Bovine Innate Immune Microar-
ray. Individual transcripts within the Lucidea RNA mix are
present in a range of concentrations. The Lucidea RNA
mix was included in the cDNA synthesis reaction at 4 µl
per 20 µg of sample total RNA. This generated a concen-
tration gradient of specific Lucidea transcripts of 0.1, 0.3,
1, 3, 10, 30, 100, 1000 and 3000 pg per µg of sample total
RNA. The Lucidea RNA mix was included in both the Cy3
and Cy5 labelling reactions.
Time course of differential gene expression during ConA 
stimulation of PBLs
The Bovine Innate Immune Microarray was used to ana-
lyse gene expression profiles of transcripts in bovine PBLs
in response to stimulation with ConA over a time course
of 24 h. PBLs were isolated from a healthy adult Hereford
steer (ARI, Yeerongpilly). Transcript expression in bovine
PBLs stimulated with ConA (5 µg/ml) for 0.5, 2, 4, 8 and
24 h was determined using control PBLs (unstimulated)
as the common reference. Dye swaps were included for
each of the five time points. The microarray experimental
design is depicted in figure 5(a).
Analysis of cross-species hybridisation
A direct comparison of gene expression in equivalent
ovine and bovine samples was undertaken. PBLs were iso-
lated from a healthy adult Hereford steer and a healthy
adult Merino sheep (ARI, Yeerongpilly). Total RNA was
extracted from un-stimulated ovine and bovine PBLs,
reverse transcribed using Superscript III, and labelled with
Cy3 or Cy5 as described above. Ovine, bovine and a 1:1
mixture of ovine and bovine labelled cDNA were applied
to the Bovine Innate Immune Microarray in an All-Pairs
design using dye swaps for each comparison as depicted
in figure 8(a).
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